+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Migraine Market and Competitive Landscape - 2020

  • ID: 5023523
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Migraine Market and Competitive Landscape - 2020, provides comprehensive insights into the Migraine pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Migraine market size and drug sales. It also provides insights into Migraine epidemiology and late stage pipeline.

This research covers the following: Migraine treatment options, Migraine late stage clinical trials pipeline, Migraine prevalence by countries, Migraine market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Migraine pipeline: Find out drugs in clinical trials for the treatment of Migraine by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Migraine epidemiology: Find out the number of patients diagnosed (prevalence) with Migraine by countries
  • Migraine drugs: Identify key drugs marketed and prescribed for Migraine in the US, including trade name, molecule name, and company
  • Migraine drugs sales: Find out the sales value for Migraine drugs by countries
  • Migraine market valuations: Find out the market size for Migraine drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Migraine drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Migraine drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Migraine market
  • Develop in-depth knowledge of competition and markets
  • Analyze Migraine drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Migraine market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
2 of 2
1. Migraine Treatment Options

2. Migraine Pipeline Insights
2.1. Migraine Phase 3 Clinical Trials
2.2. Migraine Phase 2 Clinical Trials
2.3. Migraine Phase 1 Clinical Trials

3. Migraine Epidemiology Analysis by Countries

4. Germany Migraine Market Insights
4.1. Marketed Drugs for Migraine in Germany
4.2. Germany Migraine Market Size & Forecast
4.3. Germany Migraine Drugs Sales Forecast
4.4. Germany Migraine Market Share Analysis

5. France Migraine Market Insights
5.1. Marketed Drugs for Migraine in France
5.2. France Migraine Market Size & Forecast
5.3. France Migraine Product Sales Forecast
5.4. France Migraine Market Share Analysis

6. Italy Migraine Market Insights
6.1. Marketed Drugs for Migraine in Italy
6.2. Italy Migraine Market Size & Forecast
6.3. Italy Migraine Product Sales Forecast
6.4. Italy Migraine Market Share Analysis

7. Spain Migraine Market Insights
7.1. Marketed Drugs for Migraine in Spain
7.2. Spain Migraine Market Size & Forecast
7.3. Spain Migraine Product Sales Forecast
7.4. Spain Migraine Market Share Analysis

8. UK Migraine Market Insights
8.1. Marketed Drugs for Migraine in UK
8.2. UK Migraine Market Size & Forecast
8.3. UK Migraine Product Sales Forecast
8.4. UK Migraine Market Share Analysis

9. Europe Migraine Market Insights
9.1. Europe Migraine Market Size & Forecast
9.2. Europe Migraine Product Sales Forecast
9.3. Europe Migraine Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Migraine Phase 3 Clinical Trials, Global, 2020
Table 2: Migraine Phase 2 Clinical Trials, Global, 2020
Table 3: Migraine Phase 1 Clinical Trials, Global, 2020
Table 4: Migraine Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Migraine in Germany, 2019
Table 6: Germany Migraine Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Migraine Product Sales ($mn), 2016 - 2024
Table 8: Germany Migraine Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Migraine in France, 2019
Table 10: France Migraine Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Migraine Product Sales ($mn), 2016 - 2024
Table 12: France Migraine Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Migraine in Italy, 2019
Table 14: Italy Migraine Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Migraine Product Sales ($mn), 2016 - 2024
Table 16: Italy Migraine Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Migraine in Spain, 2019
Table 18: Spain Migraine Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Migraine Product Sales ($mn), 2016 - 2024
Table 20: Spain Migraine Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Migraine in UK, 2019
Table 22: UK Migraine Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Migraine Product Sales ($mn), 2016 - 2024
Table 24: UK Migraine Market Events and Trends, 2016 - 2024
Table 25: Europe Migraine Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Migraine Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Migraine Pipeline by Phase (%), Global, 2020
Figure 2: Migraine Prevalence by Countries, 2016 - 2024
Figure 3: Germany Migraine Market Size ($mn), 2016 - 2024
Figure 4: Germany Migraine Product Sales ($mn), 2016 - 2024
Figure 5: Germany Migraine Market Share by Drugs (%), 2019
Figure 6: Germany Migraine Market - Future Market Share (%), 2024
Figure 7: France Migraine Market Size ($mn), 2016 - 2024
Figure 8: France Migraine Product Sales ($mn), 2016 - 2024
Figure 9: France Migraine Market Share by Drugs (%), 2019
Figure 10: France Migraine Market - Future Market Share (%), 2024
Figure 11: Italy Migraine Market Size ($mn), 2016 - 2024
Figure 12: Italy Migraine Product Sales ($mn), 2016 - 2024
Figure 13: Italy Migraine Market Share by Drugs (%), 2019
Figure 14: Italy Migraine Market - Future Market Share (%), 2024
Figure 15: Spain Migraine Market Size ($mn), 2016 - 2024
Figure 16: Spain Migraine Product Sales ($mn), 2016 - 2024
Figure 17: Spain Migraine Market Share by Drugs (%), 2019
Figure 18: Spain Migraine Market - Future Market Share (%), 2024
Figure 19: UK Migraine Market Size ($mn), 2016 - 2024
Figure 20: UK Migraine Product Sales ($mn), 2016 - 2024
Figure 21: UK Migraine Market Share by Drugs (%), 2019
Figure 22: UK Migraine Market - Future Market Share (%), 2024
Figure 23: Europe Migraine Market Size ($mn), 2016 - 2024
Figure 24: Europe Migraine Product Sales ($mn), 2016 - 2024
Figure 25: Europe Migraine Market Share by Drugs (%), 2019
Figure 26: Europe Migraine Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
Adroll
adroll